| Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy. | |
| | |
MedLine Citation:
|
PMID: 19571723 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To assess whether immunodeficiency is associated with the most frequent non-AIDS-defining causes of death in the era of combination antiretroviral therapy (cART). DESIGN: Observational multicentre cohorts. METHODS: Twenty-three cohorts of adults with estimated dates of human immunodeficiency virus (HIV) seroconversion were considered. Patients were seroconverters followed within the cART era. Measurements were latest CD4, nadir CD4 and time spent with CD4 cell count less than 350 cells/microl. Outcomes were specific causes of death using a standardized classification. RESULTS: Among 9858 patients (71 230 person-years follow-up), 597 died, 333 (55.7%) from non-AIDS-defining causes. Non-AIDS-defining infection, liver disease, non-AIDS-defining malignancy and cardiovascular disease accounted for 53% of non-AIDS deaths. For each 100 cells/microl increment in the latest CD4 cell count, we found a 64% (95% confidence interval 58-69%) reduction in risk of death from AIDS-defining causes and significant reductions in death from non-AIDS infections (32, 18-44%), end-stage liver disease (33, 18-46%) and non-AIDS malignancies (34, 21-45%). Non-AIDS-defining causes of death were also associated with nadir CD4 while being cART-naive or duration of exposure to immunosuppression. No relationship between risk of death from cardiovascular disease and CD4 cell count was found though there was a raised risk associated with elevated HIV RNA. CONCLUSION: In the cART era, the most frequent non-AIDS-defining causes of death are associated with immunodeficiency, only cardiovascular disease was associated with high viral replication. Avoiding profound and mild immunodeficiency, through earlier initiation of cART, may impact on morbidity and mortality of HIV-infected patients. |
| | |
Authors:
|
Benoît Marin; Rodolphe Thiébaut; Heiner C Bucher; Virginie Rondeau; Dominique Costagliola; Maria Dorrucci; Osamah Hamouda; Maria Prins; Sarah Walker; Kholoud Porter; Caroline Sabin; Geneviève Chêne |
Related Documents
:
|
9415343 - Pre-aids deaths in hiv infection related to intravenous drug use. 3381793 - The medical examiner and aids. death certification, safety procedures, and future medic... 1304773 - Aids awareness amongst school teachers in a rural area of india. |
Publication Detail:
|
Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: AIDS (London, England) Volume: 23 ISSN: 1473-5571 ISO Abbreviation: AIDS Publication Date: 2009 Aug |
Date Detail:
|
Created Date: 2009-08-17 Completed Date: 2009-12-14 Revised Date: 2012-03-19 |
Medline Journal Info:
|
Nlm Unique ID: 8710219 Medline TA: AIDS Country: England |
Other Details:
|
Languages: eng Pagination: 1743-53 Citation Subset: IM; X |
Affiliation:
|
INSERM, U897, Bordeaux, France |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
AIDS-Related Opportunistic Infections
/
immunology,
mortality Acquired Immunodeficiency Syndrome / complications, drug therapy, immunology, mortality* Adolescent Adult Aged Antiretroviral Therapy, Highly Active CD4 Lymphocyte Count Cardiovascular Diseases / complications, immunology, mortality Epidemiologic Methods Female Humans Immune Tolerance Liver Diseases / complications, immunology, mortality Male Middle Aged Neoplasms / complications, immunology, mortality Young Adult |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Does sex in the early period after circumcision increase HIV-seroconversion risk? Pooled analysis of...
Next Document: A case of dementia with PRNP D178Ncis-129M and no insomnia.